As of the latest SEC filings, Evommune, Inc. (EVMN) is held by 102 institutional funds. The largest fund shareholder is Eventide Healthcare & Life Sciences Fund (ETAHX), holding an estimated $21,613,335.81 in market value, representing 1.36% of its portfolio.
Funds holding Evommune, Inc. (EVMN)
Source: SEC Form N-PORT institutional portfolio disclosures
- Ticker:
- EVMN
- CIK:
- 0002044725
| Fund | Type | Manager | Weight | Market Value | Shares |
Report Date
|
Filing Date
|
|---|---|---|---|---|---|---|---|
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 1.36% | $21,613,335.81 | 940,119 | Mar 31, 2026 | May 29, 2026 |
|
PGSGX
JPMorgan Small Cap Growth Fund
|
MF | JPMorgan | 0.65% | $14,150,804.80 | 615,520 | Mar 31, 2026 | May 29, 2026 |
|
ANOIX
Small Cap Growth Fund
|
MF | American Century | 0.18% | $8,978,716.60 | 377,257 | Apr 30, 2026 | Jun 26, 2026 |
|
PRJIX
T. Rowe Price New Horizons Fund, Inc.
|
MF | T. Rowe Price | 0.07% | $8,339,162.70 | 362,730 | Mar 31, 2026 | May 28, 2026 |
|
FKASX
Federated Hermes Kaufmann Small Cap Fund
|
MF | Federated Hermes | 0.27% | $7,735,000.00 | 325,000 | Apr 30, 2026 | Jun 23, 2026 |
|
VTI
VANGUARD TOTAL STOCK MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $7,331,442.03 | 318,897 | Mar 31, 2026 | May 28, 2026 |
|
ETAHX
Eventide Healthcare & Life Sciences Fund
|
MF | Independent / Boutique | 0.39% | $6,184,539.90 | 269,010 | Mar 31, 2026 | May 29, 2026 |
|
PRHSX
T. Rowe Price Health Sciences Fund, Inc.
|
MF | T. Rowe Price | 0.05% | $5,657,655.08 | 246,092 | Mar 31, 2026 | May 28, 2026 |
|
IWM
iShares Russell 2000 ETF
|
ETF | BlackRock / iShares | 0.01% | $5,555,740.41 | 241,659 | Mar 31, 2026 | May 28, 2026 |
|
VSCCX
JPMorgan Small Cap Blend Fund
|
MF | JPMorgan | 0.32% | $4,568,411.87 | 198,713 | Mar 31, 2026 | May 29, 2026 |
|
PRDSX
T. Rowe Price Integrated U.S. Small-Cap Growth Equity Fund
|
MF | T. Rowe Price | 0.05% | $3,880,712.00 | 168,800 | Mar 31, 2026 | May 28, 2026 |
|
VEMPX
VANGUARD EXTENDED MARKET INDEX FUND
|
ETF | Vanguard | 0.00% | $2,870,761.30 | 124,870 | Mar 31, 2026 | May 28, 2026 |
|
HQH
abrdn Healthcare Investors
|
CEF | abrdn / Aberdeen | 0.24% | $2,782,594.65 | 121,035 | Mar 31, 2026 | May 29, 2026 |
|
FSSNX
Fidelity Small Cap Index Fund
|
MF | Fidelity | 0.01% | $2,472,010.80 | 103,866 | Apr 30, 2026 | Jun 26, 2026 |
|
CZMSX
Multi-Manager Small Cap Equity Strategies Fund
|
MF | Columbia Threadneedle | 0.19% | $2,376,608.00 | 91,408 | Feb 28, 2026 | Apr 27, 2026 |
|
HQL
abrdn Life Sciences Investors
|
CEF | abrdn / Aberdeen | 0.24% | $1,340,431.95 | 58,305 | Mar 31, 2026 | May 29, 2026 |
|
FSMAX
Fidelity Extended Market Index Fund
|
MF | Fidelity | 0.00% | $1,264,666.00 | 48,641 | Feb 28, 2026 | Apr 24, 2026 |
|
SCHA
Schwab U.S. Small-Cap ETF
|
ETF | Charles Schwab | 0.01% | $1,168,154.00 | 44,929 | Feb 28, 2026 | Apr 24, 2026 |
|
IWO
iShares Russell 2000 Growth ETF
|
ETF | BlackRock / iShares | 0.01% | $1,017,652.35 | 44,265 | Mar 31, 2026 | May 28, 2026 |
|
VVSGX
Small Cap Growth Fund
|
MF | Corebridge / VALIC | 0.18% | $1,000,974.00 | 38,499 | Feb 28, 2026 | Apr 29, 2026 |
|
IWN
iShares Russell 2000 Value ETF
|
ETF | BlackRock / iShares | 0.01% | $941,946.28 | 40,972 | Mar 31, 2026 | May 28, 2026 |
|
TQSAX
T. Rowe Price Integrated U.S. Small-Mid Cap Core Equity Fund
|
MF | T. Rowe Price | 0.05% | $645,145.38 | 28,062 | Mar 31, 2026 | May 28, 2026 |
|
IWC
iShares Micro-Cap ETF
|
ETF | BlackRock / iShares | 0.05% | $607,280.85 | 26,415 | Mar 31, 2026 | May 28, 2026 |
|
SWSSX
Schwab Small-Cap Index Fund
|
MF | Charles Schwab | 0.01% | $545,615.00 | 22,925 | Apr 30, 2026 | Jun 25, 2026 |
|
SWSCX
Schwab Small-Cap Equity Fund
|
MF | Charles Schwab | 0.08% | $539,260.40 | 22,658 | Apr 30, 2026 | Jun 25, 2026 |
Advertisement (320x50)